AKT inhibition as a therapeutic strategy to constrain histological transdifferentiation in EGFR-mutant lung adenocarcinoma Meeting Abstract
| Authors: | Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Rekhtman, N.; Houck-Loomis, B.; Koche, R. P.; Yu, H. A.; Sen, T.; Rudin, C. M. |
| Abstract Title: | AKT inhibition as a therapeutic strategy to constrain histological transdifferentiation in EGFR-mutant lung adenocarcinoma |
| Meeting Title: | 2022 World Conference on Lung Cancer |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 17 |
| Issue: | 9 Suppl. |
| Meeting Dates: | 2022 Aug 6-9 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-09-01 |
| Start Page: | S602 |
| Language: | English |
| DOI: | 10.1016/j.jtho.2022.07.1091 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: EP16.03-030 -- Located within section named "EP16.03 Tumor Biology And Biomarkers - Molecular Profiling And Targeted Therapeutics" -- Accession Number: 159038337 -- Entry Date: In Process -- Revision Date: 20220913 -- Publication Type: Article -- Supplement Title: 2022 Supplement -- Journal Subset: Biomedical; Blind Peer Reviewed; Peer Reviewed; USA -- NLM UID: 101274235. -- Source: Cinahl |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
